Returned by a PubMed search for tirzepatide

Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of Weight Loss; A Systematic Review.

Current drug safety2026PMID 39484756

Efficacy of tirzepatide for weight loss and it's comparative effectiveness to weight loss surgery in inflammatory bowel disease.

Indian journal of gastroenterology2026PMID 40682732

Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review.

Clinical obesity2026PMID 40832978

Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis.

Reviews in endocrine & metabolic disorders2026PMID 41032183

People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment.

Obesity (Silver Spring, Md.)2026PMID 41187013

Tirzepatide and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial.

Annals of the rheumatic diseases2026PMID 41198460

The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis.

Expert opinion on drug safety2026PMID 41200927

GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis.

Metabolism: clinical and experimental2026PMID 41207615

Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial.

Diabetes care2026PMID 41264593

Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial.

JAMA internal medicine2026PMID 41284285

Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial.

Diabetes, obesity & metabolism2026PMID 41290555

Cardiovascular Outcomes in Adults With Type 2 Diabetes Treated With Tirzepatide: A Systematic Review and Meta-Analysis of Real-World Studies.

Endocrine practice2026PMID 41297885

Safety and effectiveness of tirzepatide during Ramadan fasting: Real-world evidence from patients with type 2 diabetes in Bangladesh.

Diabetes, obesity & metabolism2026PMID 41342185

A real-world study of tirzepatide for weight loss in adults without diabetes mellitus.

International journal of obesity (2005)2026PMID 41354867

Tirzepatide is Associated With Reduced Risk of Primary Open-Angle Glaucoma and Ocular Hypertension in Patients With Type 2 Diabetes.

American journal of ophthalmology2026PMID 41360342

Association between tirzepatide use and risk of mortality, hospitalization, and suicidal behavior in patients with schizophrenia spectrum disorders: A one-year retrospective cohort study of 3618 patients.

European neuropsychopharmacology2026PMID 41389474

Major adverse cardiovascular and limb events caused by tirzepatide in patients with type 2 diabetes at high cardiovascular risk: A comparison with sitagliptin.

Diabetes research and clinical practice2026PMID 41448390

Effectiveness and adherence in a tirzepatide-supported digital weight-loss programme in Australia: A real-world observational study.

Diabetes, obesity & metabolism2026PMID 41532325

Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study.

Hepatology international2026PMID 41535629

Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies.

Postgraduate medical journal2026PMID 41536268

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.

Obesity (Silver Spring, Md.)2026PMID 41537305

Digital Engagement Significantly Enhances Weight Loss Outcomes in Adults With Obesity Treated With Tirzepatide: Retrospective Cohort Study of a Digital Weight Loss Service.

Journal of medical Internet research2026PMID 41538282

Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial.

Nature medicine2026PMID 41540105

Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter US Cohort Study.

Ophthalmology2026PMID 41577258

Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT-1 Trial.

Obesity (Silver Spring, Md.)2026PMID 41612966

Ocular Outcomes with Tirzepatide versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes.

Ophthalmology. Retina2026PMID 41655764

Real-world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes: A multi-site retrospective study.

Diabetes, obesity & metabolism2026PMID 41674229

Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.

Diabetes, obesity & metabolism2026PMID 41705736

Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis.

Cardiovascular diabetology2026PMID 41761267Also tests tirzepatide

Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes.

Diabetes technology & therapeutics2026PMID 41804540

Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study.

The American journal of cardiology2026PMID 41862113

Efficacy and safety of Tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis.

Disease-a-month2026PMID 41862384

Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy.

The Journal of clinical endocrinology and metabolism2026PMID 41866320

Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials.

JAMA network open2026PMID 41885866Also tests tirzepatide

The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.

BMC medicine2026PMID 41896878Also tests tirzepatide

Real-World Weight-Loss Outcomes in Weight-Reduced Patients Treated With Tirzepatide.

Obesity (Silver Spring, Md.)2026PMID 41902614

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.

Arthritis & rheumatology (Hoboken, N.J.)2026PMID 41903163

Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial.

JAMA cardiology2026PMID 41903177

Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH.

BMJ open diabetes research & care2026PMID 41912265

Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials.

Internal and emergency medicine2026PMID 41917519

Dose-response analysis of tirzepatide and acute pancreatitis: An international systematic review and quantitative meta-analysis of randomised trials.

Pancreatology2026PMID 41927408

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Diabetes care2026PMID 41940793

Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

Diabetes, obesity & metabolism2026PMID 41944182

Short-Term Associations Between Fat-Free Mass Preservation and Glycaemic Markers During Tirzepatide Therapy: A Secondary Exploratory Analysis.

Nutrients2026PMID 41978142

Tirzepatide therapy reduces subclinical leaflet thrombosis and paravalvular leak after transcatheter aortic valve replacement in obese patients: The TAVR-MET trial.

Cardiovascular revascularization medicine2026PMID 42000295

Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real-World Evidence.

Endocrinology, diabetes & metabolism2026PMID 42007544

Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort study.

Diabetes research and clinical practice2026PMID 42009260

Six-Month Real-World Effectiveness, Persistence and Safety of Low-to-Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study.

Diabetes, obesity & metabolism2026PMID 42037110

Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.

Nutrients2026PMID 42075085

Short-term effect of tirzepatide on serum calcitonin in adults with obesity.

Endocrine2026PMID 42081121